Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 10, 2025

November 10, 2025

Surgery Partners, Inc. Announces Third Quarter 2025 Results

GlobeNewswire

November 10, 2025

Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer

GlobeNewswire

November 10, 2025

Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 10, 2025

Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments

GlobeNewswire

November 10, 2025

OneMedNet Delivers on Revenue Model Promise with Palantir-Powered RWD Subscriptions: Live Feeds & AI Search

GlobeNewswire

November 10, 2025

Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System

GlobeNewswire

November 10, 2025

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

GlobeNewswire

November 10, 2025

Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 10, 2025

Immunocore to present at upcoming investor conferences

GlobeNewswire

November 10, 2025

ONL Therapeutics to Present at EYENOVATE and the FLORetina–ICOOR Congress 2025

GlobeNewswire

November 10, 2025

Editas Medicine Announces Third Quarter 2025 Results and Business Updates

GlobeNewswire

November 10, 2025

Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody

GlobeNewswire

November 10, 2025

Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 10, 2025

Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth

GlobeNewswire

November 10, 2025

Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire

November 10, 2025

HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer

GlobeNewswire

November 10, 2025

Lifeward to Report Third Quarter Financial Results on November 14, 2025

GlobeNewswire

November 10, 2025

AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression

GlobeNewswire

November 10, 2025

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

GlobeNewswire

November 10, 2025

Galecto Announces Acquisition of Damora Therapeutics

GlobeNewswire